Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical strengthens management team

Henk Doude van Troostwijk becomes vice president, commercial operations

Swedish biopharmaceutical company Hansa Medical has appointed Henk Doude van Toostwijk as its new vice president, commercial operations.

In his new role, van Troostwijk will be responsible for overseeing the firm's commercial assessments of its lead project IdeS, an orphan drug in development for organ rejection.

Goran Arvidson, president and chief executive of Hansa Medical, said: “We are very excited that Henk will engage in Hansa Medical, as we now start to prepare our commercialisation strategy for IdeS.”

Van Troostwijk brings over 20 years of sales and marketing experience in transplantation and orphan drugs, most recently as general manager of emerging markets at Raptor Pharmaceuticals.

He has also held a number of management positions at Bioenvisions, Bristol-Myers Squibb, Merck as well as serving as business unit director oncology and transplantation for Genzyme. 

27th May 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...